Axiom Space, the leading space infrastructure developer, has teamed up with Burjeel Holdings PLC, a premier super-specialty healthcare services provider in MENA region.
The partnership aims to conduct science research and test new technologies in space, expanding access to microgravity for medical advancements. The signing ceremony, took place at the Burjeel Institute for Global Health in New York, was attended by Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, and Mr. John Sunil, CEO of Burjeel Holdings.
Under the partnership, Axiom Space and Burjeel are set to send a suite of medical capabilities to space with a focus on advancing science research on how the human body reacts in microgravity. The suite features top technologies used in hospitals and clinics around the world, including Burjeel Holdings’ flagship facility Burjeel Medical City (BMC).
The research aims to study the impact of microgravity environment on biomarkers, drug substance quality, and remote health services. Axiom Space astronaut(s) intend to wear and operate these technologies remotely throughout their training, launch, and during Axiom Mission 4, which is expected to launch next spring.
Dr. Shamsheer Vayalil Founder and Chairman – Burjeel Holdings
“Through our groundbreaking partnership with Axiom Space, we are not only advancing the frontiers of medical innovation in microgravity, but we are also ensuring that both patients in the UAE and around the globe benefit from next-generation healthcare solutions. This collaboration aligns seamlessly and supports the UAE’s ambitious vision for space exploration. Just as we continue to reap the benefits of innovations from the space missions over 50 years ago transforming everything from telecommunications to medical imaging this collaboration represents a commitment to harnessing the unique environment of space to develop and enhance treatment methodologies. Ultimately, we are laying the foundation for improved patient outcomes today and for generations to come.”
Dr. Lucie Low, Axiom Space Chief Scientist, commented that, “This partnership with Burjeel Holdings underscores how Axiom Space is providing opportunities for organizations around the world to conduct medical research in space. We’re reimagining the way humans live and work in low-Earth orbit by leveraging microgravity to further our understanding of the human body, while also educating the global community on how to employ the microgravity environment for advancements in science and technology to benefit humanity.”
This partnership will set a lasting framework for collaborative exploration between the two parties, opening the microgravity environment to new users and space explorers, and elevating Burjeel’s healthcare innovation ambitions.
